TMEFF1 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8IYR6 |
---|---|
Clone Names | 100416199 |
Gene ID | 100526694;8577 |
---|---|
Other Names | Tomoregulin-1, TR-1, H7365, Transmembrane protein with EGF-like and one follistatin-like domain, TMEFF1, C9orf2 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13412b was selected from the C-term region of TMEFF1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TMEFF1 |
---|---|
Synonyms | C9orf2 |
Function | May inhibit NODAL and BMP signaling during neural patterning (By similarity). May be a tumor suppressor in brain cancers. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Expressed predominantly in brain, and at lower levels in heart, placenta and skeletal muscle. Down-regulated in brain tumors as compared to control brain tissues |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
TMEFF1 may inhibit NODAL and BMP signaling during neural patterning (By similarity). May be a tumor suppressor in brain cancers.
References
Letra, A., et al. Am. J. Med. Genet. A 152A (7), 1701-1710 (2010) :Harms, P.W., et al. Genes Dev. 17(21):2624-2629(2003)Gery, S., et al. Oncogene 22(18):2723-2727(2003)Eib, D.W., et al. Cytogenet. Cell Genet. 81 (3-4), 180-181 (1998) :Eib, D.W., et al. J. Neurochem. 67(3):1047-1055(1996)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.